Research Areas
- Ageing
- Anaesthesia, Perioperative Medicine, and Critical Care
- Cancer
- Cardiovascular
- COVID-19
- Dermatology
- Diabetes
- Ear, Nose and Throat
- Gastroenterology
- Genetics
- Haematology
- Hepatology
- Infectious Diseases
- Mental Health
- Metabolic and Endocrine
- Musculoskeletal Health
- Neuroprogressive and Dementia
- Ophthalmology
- Oral and Dental
- Paediatrics
- Pain
- Primary Care
- Regenerative Medicine
- Renal
- Reproductive Health and Childbirth
- Respiratory
- Stroke
- Transplant
- Trauma and Emergencies
Neuroprogressive and Dementia Disease
The Neuroprogressive and Dementia Network is funded by the Chief Scientist Office to promote a culture of clinical research in dementia across Scotland and improve recruitment to high-quality studies from both urban and rural areas.
The Network has grown from four centres in Grampian, Greater Glasgow & Clyde, Lothian and Tayside to now cover the whole of mainland Scotland.
We support researchers from across a range of disciplines and deliver this research across Scotland in a wide range of healthcare settings, including primary and community care, mental health services and acute hospitals. Research capacity in Huntington’s disease and Motor Neurone Disease is also being increased with 3-year Clinical Research Fellowships being jointly funded with CSO.
Close working with colleagues from Mental Health and Age and Ageing also ensures high levels of collaboration across Scotland.
Neuroprogressive and Dementia Research Strategy 2022 - 2027
The strategy sets out our intention to involve, engage with, and support people with lived experience of neuroprogressive conditions or dementia, and explore how we achieve involvement of our partners in research in all facets of our network.
Our research strategy is overseen by our Advisory Board which includes external academic advisers, a carer, and a representative from Alzheimer Scotland.
- Year Two annual report - 2023/24
- Summary - NRS NDN Strategy 2022 - 2027
- Read the NRS NDN Strategy 2022 - 2027